Manager × security

Vitruvian Partners LLP MXCT holdings history

Who else holds this security? →

MAXCYTE INC · CUSIP 57777K106 · CIK 1692590

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Vitruvian Partners LLP reported 5.04M MXCT (shares), valued at $6.20M, or 3.09% of its reported non-derivative portfolio. Filed 2026-08-10.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
3.09%
Shares
5.04M
5,043,356
Reported value
$6.20M
USD

Shares unchanged; reported value increased 75.09%, and weight changed -0.08 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20263.09%5,043,356SEC filing ↗Filed Aug 10, 2026
Q1 20263.17%5,043,356SEC filing ↗Filed May 11, 2026
Q4 20255.62%5,043,356SEC filing ↗Filed Feb 6, 2026
Q3 20255.53%5,043,356SEC filing ↗Filed Nov 10, 2025
Q2 20256.70%5,043,356SEC filing ↗Filed Aug 11, 2025
Q1 202513.13%5,043,356SEC filing ↗Filed May 8, 2025
Q4 202418.06%5,043,356SEC filing ↗Filed Feb 11, 2025
Q3 20247.62%5,043,356SEC filing ↗Filed Nov 12, 2024
Q2 20245.80%5,043,356SEC filing ↗Filed Jul 18, 2024
Q1 20246.70%5,043,356SEC filing ↗Filed May 14, 2024
Q4 20236.02%5,043,356SEC filing ↗Filed Feb 9, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20236.02%5,043,356$23.70MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 9, 2024
Q1 20246.70%5,043,356$21.13MShares unchanged; reported value decreased 10.85%, and weight changed +0.68 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 20245.80%5,043,356$19.77MShares unchanged; reported value decreased 6.44%, and weight changed -0.90 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 18, 2024
Q3 20247.62%5,043,356$19.62MShares unchanged; reported value decreased 0.77%, and weight changed +1.82 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2024
Q4 202418.06%5,043,356$20.98MShares unchanged; reported value increased 6.94%, and weight changed +10.44 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 11, 2025
Q1 202513.13%5,043,356$13.77MShares unchanged; reported value decreased 34.37%, and weight changed -4.93 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 8, 2025
Q2 20256.70%5,043,356$10.99MShares unchanged; reported value decreased 20.15%, and weight changed -6.43 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2025
Q3 20255.53%5,043,356$7.97MShares unchanged; reported value decreased 27.52%, and weight changed -1.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 10, 2025
Q4 20255.62%5,043,356$7.82MShares unchanged; reported value decreased 1.90%, and weight changed +0.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 6, 2026
Q1 20263.17%5,043,356$3.54MShares unchanged; reported value decreased 54.68%, and weight changed -2.45 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 11, 2026
Q2 20263.09%5,043,356$6.20MShares unchanged; reported value increased 75.09%, and weight changed -0.08 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 10, 2026
Vitruvian Partners LLP · MAXCYTE INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1692590","quarter":"2026Q2","cusip":"57777K106"}

get_institutional_manager_history
{"cik":"1692590","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.